Effects of different dosages/frequency of Xuebijing injection (a Chinese patent) for sepsis: a network meta-analysis of randomized controlled trials by Guangyan Liu, Guangyan Liu, Xueping Qu, Xueping Qu, Ruowen Jiang, Ruowen Jiang, Yongxing Wu, Yongxing Wu, Zan Qin, Zan Qin, Hui Zhang, Hui Zhang, Ruze Ma, Ruze Ma, Jiawei Xue, Jiawei Xue, Junwu Wang, Junwu Wang, Xueqin Xu, Xueqin Xu, Chenxi Yan, Chenxi Yan, Xiaodan Wei, Xiaodan Wei, Litao Guo, Litao Guo

Get full text

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer by Xueping Qu, Habib Hamidi, Radia M. Johnson, Ethan S. Sokol, Eva Lin, Cathy Eng, Tae Won Kim, Johanna Bendell, Smruthy Sivakumar, Benjamin Kaplan, Felipe de Sousa e Melo, Andrew Mancini, Matthew Wongchenko, Yi Shi, David Shames, Yibing Yan, Fortunato Ciardiello, Carlos Bais

Get full text